ENST00000377993.8:n.1017+2333C>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000377993.8(CMAHP):​n.1017+2333C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.614 in 152,020 control chromosomes in the GnomAD database, including 31,231 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.61 ( 31231 hom., cov: 32)

Consequence

CMAHP
ENST00000377993.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.169

Publications

4 publications found
Variant links:
Genes affected
CMAHP (HGNC:2098): (cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene) Sialic acids are terminal components of the carbohydrate chains of glycoconjugates involved in ligand-receptor, cell-cell, and cell-pathogen interactions. The two most common forms of sialic acid found in mammalian cells are N-acetylneuraminic acid (Neu5Ac) and its hydroxylated derivative, N-glycolylneuraminic acid (Neu5Gc). Studies of sialic acid distribution show that Neu5Gc is not detectable in normal human tissues although it was an abundant sialic acid in other mammals. Neu5Gc is, in actuality, immunogenic in humans. The absense of Neu5Gc in humans is due to a deletion within the human gene CMAH encoding cytidine monophosphate-N-acetylneuraminic acid hydroxylase, an enzyme responsible for Neu5Gc biosynthesis. Sequences encoding the mouse, pig, and chimpanzee hydroxylase enzymes were obtained by cDNA cloning and found to be highly homologous. However, the homologous human cDNA differs from these cDNAs by a 92-bp deletion in the 5' region. This deletion, corresponding to exon 6 of the mouse hydroxylase gene, causes a frameshift mutation and premature termination of the polypeptide chain in human. It seems unlikely that the truncated human hydroxylase mRNA encodes for an active enzyme explaining why Neu5Gc is undetectable in normal human tissues. Human genomic DNA also shows evidence of this deletion which does not occur in the genomes of African great apes. Nonetheless, the CMAH gene maps to 6p21.32 in humans and great apes indicating that mutation of the CMAH gene occurred following human divergence from chimpanzees and bonobos. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.793 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CMAHPNR_002174.2 linkn.1009+2333C>A intron_variant Intron 7 of 12

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CMAHPENST00000377993.8 linkn.1017+2333C>A intron_variant Intron 8 of 13 1
CMAHPENST00000377989.8 linkn.1529+2333C>A intron_variant Intron 8 of 13 2
CMAHPENST00000490939.1 linkn.243+2333C>A intron_variant Intron 2 of 5 3

Frequencies

GnomAD3 genomes
AF:
0.615
AC:
93344
AN:
151902
Hom.:
31221
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.322
Gnomad AMI
AF:
0.792
Gnomad AMR
AF:
0.720
Gnomad ASJ
AF:
0.727
Gnomad EAS
AF:
0.814
Gnomad SAS
AF:
0.791
Gnomad FIN
AF:
0.740
Gnomad MID
AF:
0.677
Gnomad NFE
AF:
0.712
Gnomad OTH
AF:
0.637
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.614
AC:
93373
AN:
152020
Hom.:
31231
Cov.:
32
AF XY:
0.621
AC XY:
46172
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.322
AC:
13333
AN:
41428
American (AMR)
AF:
0.720
AC:
11000
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.727
AC:
2524
AN:
3472
East Asian (EAS)
AF:
0.814
AC:
4203
AN:
5164
South Asian (SAS)
AF:
0.792
AC:
3819
AN:
4820
European-Finnish (FIN)
AF:
0.740
AC:
7831
AN:
10576
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.712
AC:
48387
AN:
67966
Other (OTH)
AF:
0.642
AC:
1355
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1584
3168
4753
6337
7921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
760
1520
2280
3040
3800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.689
Hom.:
15809
Bravo
AF:
0.598
Asia WGS
AF:
0.785
AC:
2731
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.1
DANN
Benign
0.79
PhyloP100
-0.17

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3812105; hg19: chr6-25104254; API